The convergence of seemingly disparate realms – male enhancement medications, volatile copyright, and the intoxicating allure of gambling – presents a fascinating, if occasionally unpredictable, scenario for a certain group of investors. Some are drawn to the perceived “advantage” that combining these areas might provide; perhaps a rapid in